Goto content

Leishrisk, Bridging Research and Leishmanianis Control

Leishrisk, Bridging Research and Leishmanianis Control

LeishRisk workshop presentations

Session 1: Methods

'Diagnosis'
by Suman Rijal (B.P Koirala Institute of Health Sciences, Nepal)

'Molecular epidemiology'
by Gabriele Schönian (Charité University Medicine Berlin, Germany)

'Treatment'
by Gustavo Romero (Universidade de Brasília, Brazil)

'Methods for vector control'
by Michele Maroli (Istituto Superiore di Sanità, Italy)

 

Session 2: Environmental changes

'Domestication of transmission cycles of Cutaneous Leishmaniasis in Latin America'
by Ana Lineth Garcia Orellana (Universidad Mayor de San Simón, Bolivia)

'Changes in climate, land use and social behaviour & the emergence of leishmaniasis in Eurasia and Africa'
by Paul Ready (Natural History Museum, UK)

'Emergence of leishmaniasis in northern Italy since 1990'
by Marina Gramiccia (Istituto Superiore di Sanità, Italy)

'ECDC and vector-borne disease'
by Evelyn Depoortere (European Centre for Disease Prevention and Control, Sweden)

 

Session 3: Treatment failure and drug resistance

'Antimonial Resistance & Combination therapy in Indian Visceral Leishmaniasis'
by Shyam Sundar (Banaras Hindu University, India)

'Host factors related with treatment failure in Leishmaniasis'
by Syamal Roy (Indian Institute of Chemical Biology, India)

'Complexity of treating New World Cutaneous Leishmaniasis'
by Byron Arana (Universidad del Valle, Guatemala)

'Treatment failure & drug resistance in Visceral Leishmaniasis'
by Saskia Decuypere (University of Strathclyde, UK)

 

Session 4: Immunity and vaccination

'Immunotherapy of leishmaniases'
by Farrokh Modabber (Drugs for Neglected Diseases Initiative, Switzerland)

'Situation of HIV co-infection'
by Jorge Alvar (World Health Organization, Switzerland)  presentation not yet available

'Effective immunological mechanisms of resistance against Leishmania'
by Hechmi Louzir (Institut Pasteur de Tunis, Tunisia)

'Leishmaniasis: Challenges for vaccine development'
by Steven G. Reed (Infectious Disease Research Institute, US)

 

Session 5: Control and update on interventions

'The VL elimination initiative in the Indian subcontinent: Current status and future challenges'
by Suman Rijal (B.P Koirala Institute of Health Sciences, Nepal) and Chusak Prasittisuk (WHO Regional Office for South East Asia, India)

'Kala-Azar elimination programme in India'
by S.N. Sharma (National Vector Borne Disease Controle Programme, India)

'iOWH and VL control in Bihar State, India'
by Philippe Desjeux (Institute for OneWorld Health, US)

'MSF and VL Control in East Africa: Operational Challenges'
by Koert Ritmeijer (Médecins sans Frontières Holland, Amsterdam)

'Diagnostic Tools for the Elimination of Visceral Leishmaniasis'
by Marleen Boelaert (Intitute of Tropical Medicine Antwerp, Belgium) and Rosanna W. Peeling (Special Programme for Research and Training in Tropical Diseases)

Search

news

LeishRisk supports the initiative to develop a VL Diagnostics Quality Assurance Network.  

Download a report of the first consultation meeting <here>